Effects of serotonin transporters on myocardial cell injury during ischemia/reperfusion in rats
Open Access
- 30 June 2026
- journal article
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 76 (3) , 100085
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Monoamine oxidases as sources of oxidants in the heartJournal of Molecular and Cellular Cardiology, 2014
- Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injuryBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connectionCellular and Molecular Life Sciences, 2005
- Sertraline Causes Strong Coronary Vasodilation: Possible Relevance for Cardioprotection by Selective Serotonin Reuptake InhibitorsCardiovascular Drugs and Therapy, 2004
- The role of serotonin in ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit heartsJACC, 2002
- Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetineBiological Psychiatry, 2001
- Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopramEuropean Journal of Pharmacology, 2000
- Reactive oxygen species production by monoamine oxidases in intact cellsNaunyn-Schmiedeberg's Archives of Pharmacology, 1999
- Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publicationLife Sciences, 1995
- Divergent Effects of Serotonin on Coronary-Artery Dimensions and Blood Flow in Patients with Coronary Atherosclerosis and Control PatientsNew England Journal of Medicine, 1991